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Interleukin-lß mRNA Expression 
in Ischemic Rat Cortex 
T. Liu, MD; P.e. Mc Donnell, MS; P.R. Young, PhD; R.F. White, BA; A.L. Siren, MD, PhD; 
I.M. Hallenbeck, MD; F.e. Barone, PhD; G.Z. Feuerstein, MD 
Background and Pur pose: Interleukin-1ß is a proinftammatory cytokine produced by blood-borne and 
resident brain inftammatory cells. The present study was conducted to determine if interleukin-1ß mRNA 
was produced in the brain of rats subjected to permanent focal ischemia. 
Methods: Rat interleukin-1ß cDNA, synthesized from stimulated rat peritoneal macrophage RNA by 
reverse transcription and polymerase chain reaction and c10ned in plasmid Bluescript KS+, was used to 
evaluate the expression of interleukin-1ß mRNA in cerebral cortex from spontaneously hypertensive rats 
and normotensive rats subjected to permanent middle cerebral artery occlusion. Interleukin-1ß mRNA 
was quantified by Northern blot analysis and compared with rat macrophage RNA standard. To correct 
for gel loading, blots were also analyzed with cyclophilin cDNA, which encodes an abundant, conserved 
protein that was unchanged by the experimental conditions. 
Results: Interleukin-1ß mRNA produced in the ischemic zone was significantly increased from 6 hours 
to 120 hours, with a maximum of211±24% ofinterleukin-1ß reference standard, ie, 0.2 ng stimulated rat 
macrophage RNA, mRNA compared with the level in nonischemic cortices (4±2%) at 12 hours after 
ischemia (P<.OI; n=6). Interleukin-1ß mRNA at 12 hours after ischemia was markedly elevated in 
hypertensive rats over levels found in two normotensive rat strains. Neurological deficits were also 
apparent only in the hypertensive rats. 
Conclusions: Brain interleukin-1ß mRNA is elevated acutely after permanent focal ischemia and 
especially in hypertensive rats. These data suggest that this potent proinflammatory and procoagulant 
cytokine might have a role in brain damage following ischemia. (Stroke. 1993;24:1746-1751.) 
KE;v WORDS • cerebra I ischemia • cytokines • neuronal damage • rats 
I nterleukin-1ß (IL-1ß) is a cytokine with multiple proinflammatory, procoagulant, and cell growth modulatory actions. 1 The presence of IL-1ß in the 
central nervous system is believed to reflect synthesis by 
diverse cells such as endothelium, microglia, astrocytes, 
and neurons.2 
Interleukin-lß acts via specific brain IL-l receptors 
that demonstrate significant spatial distribution.3 As in 
peripheral organs, the proinflammatory and prothrom-
botic actions of IL-lß1 are expected to promote acute 
neuropathological changes at excessive levels in the 
brain. Brain iscbemia has been shown to be associated 
with an acute inflammatory response,4-6 but the nature 
of the inflammatory media tors involved in brain isch-
emia is still unknown. While numerous reports have 
dealt with the putative roles of various inflammatory 
mediators such as thromboxane A2 , leukotrienes, and 
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platelet-activating factor7,8 in brain injury, few attempts 
have been made to explore the role of proinflammatory 
cytokines in brain injury. Evidence supporting the involve-
ment of cytokines in central nervous system injury in-
cludes demonstrations of IL-lß mRNA expression in 
mouse brain 3 hours after endotoxin administration,9 
release of IL-l in mechanically injured brain produced by 
intraparenchymal implantation of a microdialysis probe,lO 
expression of IL-lß mRNA in rat brain in response to 
direct intraparenchymal administration of the neurotoxin 
kainate,ll or combination of endotoxin and y-interferon.I2 
IL-lß mRNA expression was also shown in a rat model of 
transient global brain ischemia induced by permanent 
bilateral vertebral artery occlusion followed by bilateral 
carotid occlusion with reperfusion,13 However, cytokine 
transcription in permanent focal ischemia has not been 
previously evaluated. The purpose of the present study 
was to determine whether the initiation phase of IL-Iß 
production, ie, the transcription of its mRNA, takes place 
after permanent middle cerebra I artery occlusion 
(MCAO); furthermore, this study also aimed to explore 
the differences, if any, between rats carrying risk factors 
for stroke (eg, hypertension) and normotensive rats. 
Materials and Methods 
To provide IL-lß mRNA for use as a standard and to 
create the necessary IL-Iß cDNA probe for Northern 
blot analysis, rat peritoneal macrophages were collected 
by lavage with phosphate-buffered saline and incubated 
with 5 JLg/mL Escherichia coli lipopolysaccharide (Sig-
ma Chemical Co, St Louis, Mo) at 37°C for 4 hours. 
Cells \\Iere lysed in 4 mol/L guanidinium thiocyanate, 
and total RNA was isolated by centrifugation over 5.8 
mollL CsCl.14 IL-1ß cDNA was synthesized by reverse 
transcription and polymerase chain reactions (RT-PCR; 
Boehringer Mannheim Biochemica, Indianapolis, Iod) 
using the 5' and 3' synthetic oligonucleotide primers 
5' -CAGCGGCCGCCTTGTGCAAGTGTCTGAAG-
CAG-3' and 3'-GAACAGCTCTTACCCGTCAGAG-
GTCCAGATCTCGCCGGCGAC-5', respectively. The 
primers were engineered to contain a Notl restriction 
si te for cloning purposes. The fragment obtained by 
RT-PCR was digested with Notl and ligated into Blue-
script KS+ (Stratagene, La Jolla, Calif) . The identity of 
the cD NA insert was confirmed by sequencing and 
agrees with the known sequence. 12 For Northern blot 
hybridization, the 0.9-kb rat IL-1ß cDNA insert was 
used (isolated by Notl digestion of Bluescript K + that 
contained the IL-1ß cDNA fragment and purified by 
agarose gel electrophoresis). Similarly, a human 0.9-kb 
EcoRI cyclophilin cDNA fragment was prepared and 
also used for hybridization according to Bergsma et al.l5 
Both rat IL-1ß and cyclophilin cD NA fragments were 
labeled using an oligolabeling kit (Pharmacia LKB 
Biotechnology, Piscataway, NJ) via random primer ex-
tension using Klenow DNA Polymerase land purified 
using a Nuctrap push column (Stratagene). 
Focal ischemia or sham surgery was carried out in 
spontaneously hypertensive rats (SHR; Taconic Farms, 
Germantown, NY) and in two normotensive rat strains 
(F-344 or Wistar-Kyoto; Taconic Farms) (weight, 250 to 
300 g). Animals were anesthetized with sodium pento-
barbital (Steris Laboratories, Inc, Phoenix, Az; 60 
mg/kg IP) and prepared for surgery as previously 
described.6 Briefly, via a 2- to 3-mm craniotomy the 
right middle cerebra I artery was isolated on the hooked 
tip of a platinum-irridium wire (0.0045-in diameter; 
Medwire, Mount Vernon, NY) and then simultaneously 
occluded and cut dorsal to the lateral olfactory tract 
(n==18, SHR; n==4, F-344; n==4, Wistar-Kyoto) . In 
sham-operated animals (n==3; SHR) the same surgical 
procedures were exercised, but the artery was not 
occluded, and animals were killed at 12 hours. In 
addition, nonoperated animals (n==3; SHR) were also 
studied. 
Two separate neurological examinations were per-
formed on the rats before euthanasia to determine the 
severity of motor deficits. Contralateral forelimb def-
icits were measured using a neurological grade as 
previously described,16 while contralateral hind-limb 
deficits were measured using a standard hind-limb 
placement test.6 At various times post-MCAO rats 
were overdosed with pentobarbital, and forebrains 
were removed and dissected as described previously.5.6 
A segment of the ipsilateral frontoparietal cortex was 
sliced from the hemisphere; an identical segment was 
sliced from the contralateral cortical hemisphere 
(nonischemic control). The segments were immedi-
ately frozen in liquid nitrogen and stored at -80°(;. 
For Northern blot analysis of IL-1ß mRNA in the 
focal ischemk and nonischernic tissue, total RNA from 
cortical tissues (50 JLg) and total RNA obtained from 
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peritoneal macrophages (ie, 0.2 JLg iso la ted as described 
above and used in the Northern blots as an IL-1ß 
mRNA reference standard for quantitation purposes) 
was fractioned through a 1 % agarose gel, containing 6% 
formaldehyde in MOPS (3-[N-morpholino-]propane-
sulfonic acid; Sigma). The RNA was then transferred 
onto a nitrocellulose membrane (Keene, NH; BA83, 0.2 
JLm) by capillary blotting in 20x saline-sodium phos-
phate-ethylenediaminetetraacetic acid (EDTA) 
(SSPE) (lx SSPE is 150 mmol/L NaCl, 2 mmollL 
NaH2P04 , and 1 mmollL EDTA). RNA was immobi-
lized on the filter, prehybridized, and then hybridized to 
the 32P-deoxycytidine triphosphate-labeled rat IL-1ß 
cD NA probes at 42°C for 14 to 18 hours in the buffer 
containing 50% formamide, 6x SSPE, 5 x Denhardt's 
solution, 0.5% sodium dodecyl sulfate (SDS), 100 
JLg/mL denatured salmon sperm DNA, and 10% dex-
trane sulfate and then washed to a final stringency of 
0.5 x SSPE, 0.1% SDS, at 50°C for 15 minutes. The 
membrane was exposed to Arnersham Hyperfilm-MP 
for 2 days with intensifying screen and developed by a 
Kodak M35A-OMAT processor. All the membranes 
were stripped in boiling 0.05 x SSPE and rehybridized 
to 32P-deoxycytidine triphosphate-Iabeled human cyclo-
philin cDNA to control for differences in RNA loading. 
Radioactivity of the hybridized blots was counted by 
a Betascope 603 blot analyzer (Betagen Corp, Waltham, 
Mass). Cortical tissue IL-1ß mRNA was quantitated for 
between-blot comparisons as the percent relative radio-
activity of the reference standard (ie, macrophage RNA 
loaded on the same gel normalized to the actual amount 
of RNA loaded that was determined from the cyclo-
philin mRNA counts from the same cortical sampies). 
For within-blot comparisons of ischemic cortex IL-1ß, 
percent relative radioactivity was normalized directly in 
relation to the loaded RNA determined from the cyclo-
philin mRNA in each sampie. 
All data are expressed as mean±SEM. StatistkaI 
analysis of the data was performed using analysis of 
variance and Tukey's multiple comparison tests. Signif-
icant differences were accepted at P<.05. 
Results 
Neurological deficits after focal ischemia occurred in 
SHR (Fig 1) but not in normotensive animals. Both 
forelimb and hind-limb dysfunction in SHR were ob-
served. Partial spontaneous recovery was evidenced at 5 
days for forelimb scores and at 1 and 5 days for 
hind-limb scores. 
Fig 2 illustrates the results of a representative North-
ern blot of rat cortical RNA 12 hours after MCAO. 
IL-Iß mRNA is significantly more abundant in ipsilat-
eral (top IL-1ß lanes 1 through 6) ischemic cortices than 
in the contralateral cortices (bottom IL-1ß lanes 1 
through 6) of the same animals. RNA from macro-
phages was used as the reference standard for quanti-
tation purposes (Fig 2); correcting for total loaded RNA 
was done by measurement of the cyclophilin mRNA 
(cyclophilin lanes 1 through 6) from the ischernic (top) 
and nonischemic (bottom) regions. 
Fig 3 depicts the quantitated IL-Iß mRNA levels in 
the cortices taken at various time points after MCAO. 
IL-Iß mRNA was not detectable in cortical sampies 
from nonoperated rats (O±O%, n==3). Sham surgery 
produced no significant effect. In the contralateral 
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FIG 1. Bar graphs iIIustrate graded forelimb (top) and 
hind-limb (bottom) deficits in sham (n=3) and permanent 
middle cerebral artery occlusion (n=3 to 6) in spontane-
ously hypertensive rats. *P< .05 compared with sham. 
Neurological deficits at 1 hour after middle cerebral artery 
occlusion could not be determined because of anesthe-
sia. Vertical bar lines represent SEM. 
nonischemic cortex after MCAO, a weak trend for 
expression of IL-1ß was detected that did not reach 
statistical significance. Permanent MCAO dramatically 
increased the IL-1ß mRNA level in the ipsilateral 
ischemic cortex compared with the contralateral control 
cortex from 6 hours after MCAO and up to 5 days later. 
Peak IL-1ß mRNA expression was noticed 12 hours 
after MCAO (P<.01), but significantly elevated levels 
were still monitored 5 days later (P< .05). To examine 
whether the elevated levels of IL-1ß found in the 
ischemic cortices are specific to SHR only, we have 
monitored IL-1ß mRNA in three groups (n=4 per 
group) of rats studied simultaneously (ie, killed at 12 
hours after MCAO and quantitated together). The two 
normotensive strains, WKY and F-344 rats, responded 
with much less IL-1ß mRNA expression compared with 
the SHR group (Fig 4). However, the levels of IL-1ß 
mRNA in both normotensive rat strains were signifi-
cantly elevated over background levels. 
Discussion 
This articie demonstrates that IL-1ß mRNA in rat 
brain is significantly increased in ischemic cerebral 
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FIG 2. Northern blot of interleukin-1 ß (IL-1 ß) from cere-
bral cortices after 12-hour permanent middle cerebral 
artery occlusion (n=6). Lanes 1 through 6, 50 ,ug of total 
RNA from ipsilateral (ischemic) or contralateral (nonisch-
emic) cortex was separated on 1 % agarose gel contain-
ing 6% formaldehyde, biotted into nitrocellulose mem-
brane, and then hybridized with rat cDNA IL-1 ß probe. 
Lane 7, 0.2 ,ug of total RNA was isolated from rat 
macrophages stimulated with 5 ,ug/mL lipopolysaccha-
ride loaded on the same gel. After stripping, the blot was 
hybridized with a human cyclophilin cDNA probe and 
used in quantitation of the data to control for amount of 
loaded RNA. 
tissue. The time course of IL-1ß mRNA expression 
demonstrated a trend toward increased IL-1ß mRNA 
expression as early as 1 hour after permanent MCAO, a 
definite increase at 6 hours, and persistently elevated 
IL-1ß mRNA levels up to 5 days after ischemia. The 
early IL-1ß mRNA expression, ie, 1 to 6 hours, pre-
cedes the time of leukocyte infiltration (measured by 
myeloperoxidase accumulation) from blood vessels out-
side the ischemic zone, wh ich only begins to occur after 
12 hours and then dramatically increases for aperiod of 
5 days after infarction in this modelP These data are 
further supported by a detailed histological study show-
ing significant elevation of neutrophils in ischemic cor-
tex at 48 hours after ischemia. 18 Our data also suggest 
that IL-1ß mRNA expression in focal ischemic brain 
tissue is not specific to the SHR strain since significant 
IL-1ß mRNA expression has been ciearly demonstrated 
in the two normotensive rat strains. The lesser IL-1ß 
mRNA expression in the two normotensive rat strains 
may represent the lesser vulnerability of brain cortex of 
normotensive rats to permanent MCAO,6 as also re-
flected in the present study by lack of neurological 
deficits in the normotensive rats and previous re ports on 
infarct volume.6 
The data presented in this study are in accord with 
recent reports demonstrating IL-1ß mRNA expression 
in several different brain injury models.9-13 Thus, Mi-
nami et al13 have shown acute biphasic IL-1ß mRNA 
expression in various brain regions after transient global 
ischemia. However, several important differences be-
tween the two studies must be pointed out. First, the 
present data represent transcription of IL-1ß in perma-
nent focal ischemia. Second, the previous study13 has 
Liu et al IL-Iß mRNA in Focal Ischemia 1749 
Sham 1hr MCAO 6hr MCAO 12hr MCAO 24hr MCAO 5day MCAO 
FIG 3. Bar graph illustrates quantitative analysis of the time course for interleukin-1 ß (IL-1 ß) mRNA production in 
cerebral cortices ipsilateral or contralateral to permanent middle cerebral artery occlusion (MCAO) (n=3 to 6 per time 
point) or sham surgery (n=3 killed at 12 hours). The ß-emissions from bands on hybridized Northern blots were counted 
using a Betascope counter. Data (mean±SE) from different blots are presented as percentage of loaded rat macrophage 
IL-1 ß mRNA (reference standard) normalized to the actual amount of loaded RNA (see "Materials and Methods"). *p< .05 
compared with contralateral cortex; **P<.01 compared with contralateral cortex and compared with ipsilateral cortex of 
5-day MCAO. No detectable IL-1ß mRNA was observed in either cortex of nonoperated rats (n=3; data not shown). 
Vertical bars represent SEM. 
not used a reference message (eg, cyclophilin), nor did it 
standardize its hybridization probe against a single IL-Iß 
mRNA-containing sampie such as rat macrophage IL-Iß 
mRNA. Third, and most importantly, the present study 
provides quantitated data, whereas only qualitative (visu-
al) representative gels were provided in the global isch-
emia study,13 These differences may underlie the lack of 
significant IL-Iß mRNA in the brain between 1 and 7 days 
after global brain ischernia, whereas significant IL-Iß 
mRNA was ciearly demonstrated in our study at 5 days 
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FIG 4. Bar graph illustrates quantitative analysis of isch-
emic cortex interleukin-1 ß mRNA production in groups 
(n=4) of hypertensive (spontaneously hypertensive rats 
[SHR)) and normotensive (Wistar-Kyoto [WKY] and 
Fisher) rats 12 hours after middle cerebral artery occlu-
sion. Data from one blot are presented as relative change 
normalized to the actual amount of loaded RNA (see 
"Materials and Methods"). *P<.05 compared with SHR; 
**P<.05 compared with WKY rats. 
after MCAO. The lack of standardization and quantifica-
tion of IL-Iß mRNA in the global ischernia report also 
makes it difficult to correlate the magnitude of the IL-Iß 
mRNA expression in the focal ischernic brain cortex 
described here to the changes described previously in the 
global ischernia modeJ.13 
The significance of the IL-Iß mRNA expression de-
scribed in the present study must be interpreted with 
caution because no evidence has been provided to indicate 
that translation of the message into the functional cyto-
kine has occurred either at the time of the IL-Iß mRNA 
expression or thereafter. However, the de novo expression 
of IL-Iß mRNA in the nonperfused ischernic cortex 
supports the possibility that endogenous IL-Iß rnight be 
produced in ischemic brain. This possibility draws further 
credence from reports demonstrating the capacity of the 
brain to synthesize cytokines, inciuding IL-1, in several 
other brain injury models. For example, mechanical inju-
rylO resulted in significant IL-l production 24 hours after 
injury, which compares favorably with the earlier IL-Iß 
mRNA shown in our study. Also in this latter study, IL-l 
production was significantly lower at 7 days after injury, 
again in accord with the significant diminution of IL-Iß 
mRNA observed in our study. In any case, it will be 
necessary to directly monitor IL-Iß production in focal 
brain ischemia to precisely relate the transcriptional event 
to the cytokine production. 
The cellular elements expressing IL-Iß mRNA in the 
ischemic brain have not been elucidated in the present 
study. However, IL-l has been shown to be produced by 
microglial cells in vitro19 and in viV020,21 and by astro-
cytes in vitro.22,23 Furthermore, IL-l has been detected 
in the cerebrospinal fluid of rats.24 It is also noteworthy 
that a peripheral source for IL-l might gain access into 
the brain since this cytokine was shown to be trans-
ported from the blood into the brain25; therefore, even 
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if IL-1ß is produced in the brain, this may not prec1ude 
a role for peripheral IL-1 in brain injury. 
If one accepts the possibility that the increase in 
IL-1ß mRNA shortly after ischemic stroke indeed 
translates into a robust production of this potent cyto-
kine, one must also anticipate its consequences; these 
inc1ude activation of microglia and astrocytes26 and 
transformation of the endothelium into a proinflamma-
tory and prothrombotic27 state that may propagate 
thrombosis and the extension of the ischemic zone. 
Finally, it is important to point out that IL-Iß mRNA is 
only one of many genes that are overexpressed in the 
brain after injury; most notably, acute immediate genes 
such as C-fOS,28 heat-shock protein,28.29 and the tumor 
suppressor gene product p5330 have been shown to be 
overexpressed in the brain in response to ischemia. 
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Editorial Comment 
Recent advances and research interest in molecular 
biology have prompted stroke researchers and neurosci-
entists to study gene induction and expression in ischemic 
brain. A good example of this interest is the induction and 
expression of the 70-kD stress (heat-shock) gene at both 
transcriptional and translational levels in neurons, glia, 
and endothelial cells that have been intensively investi-
gated in various models of permanent and temporary 
cerebral ischemia. 1-6 Along a similar line, using a rat 
interleukin (IL)-lß cDNA synthesized from stimulated rat 
peritoneal macrophage RNA, Liu et al have now reported 
the induction and expression of IL-Iß mRNA in the 
ischemic zone in both hypertensive and normotensive rats 
after permanent focal ischemia. Furthermore, the brain 
level of IL-Iß mRNA is increased markedJy in hyperten-
sive rats over the levels found in two different strains of 
normotensive rats. A couple of important implieations 
resulting from this interesting study might need elabora-
tion. First, the elevated levels of IL-Iß mRNA in the brain 
cortex in hypertensive rats correlate with the severity of 
the neurological deficits after permanent foeal ischemia, 
which suggests that the elevated levels of cytokine mRNA 
may playa role in ischemic brain damage. Further studies 
are warranted to address the issues of the expression of 
functional pro tein and the specificity of the cytokine in 
ischemic brain injury. Second, although the studies cIearly 
demonstrate the elevated levels of IL-Iß mRNA in the 
ischemic cortex, the cellular origin of such an expression is 
not known. Other studies have indicated that both hsp70 
mRNA and 70-kD heat-shock protein are detected in 
endothelial cells, even in the ischemic infarct area.7 The 
latter study may point to the possibility that the inflam-
matory ceHs with nonneuronal origin may account for the 
cytokine mRNA expression. Further studies using in situ 
hybridization and/or immunocytochemistry in conjunction 
with histological studies would provide much-needed in-
formation to address this question. 
Pak H. Chan, PhD, Guest Editor 
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